GSK refutes consumer spin-off rumor

Share this article:

GlaxoSmithKline is not looking to offload its consumer business. Bloomberg reports that the UK drugmaker refuted a Financial Times article that indicated a spin-off was imminent.

This does not mean it could not happen—GSK  tells Bloomberg it won't turn the consumer business into a free-standing operation “in the near term.”

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.